ALSF and RUNX1 Research Program have partnered to raise awareness and accelerate research around familial RUNX1 disorders through the RUNX1 Early Career Investigator Grant and the Familial RUNX1 Grant.
RUNX1 Early Career Investigator Grant: Up to $180,000 over three years
The purpose of the RUNX1 Early Career Investigator Grant is to promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder. We believe that providing capital to early career investigators not only injects funding into where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has had limited attention. The Program is viewed as a long-term endeavor of collaboration and data sharing. We are especially interested in innovative and cross-disciplinary approaches to developing effective therapies.
The RUNX1 Early Career Investigator Grant is currently being offered. To apply, please visit the Applicant page.
Familial RUNX1 Grant:
The purpose of the Familial RUNX1 grant is to fund research in strategies leading to the development of therapies to prevent the transition from pre-leukemia to leukemia for patients with FPD/AML. Projects focus on leukemia caused by familial RUNX1 mutations rather than sporadic AML with somatic RUNX1 mutations.